ORKA-001 Versus Placebo in Patients With Moderate-to-Severe Plaque Psoriasis

NCT07090330 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Plaque Psoriasis

Interventions

DRUG: ORKA-001 Induction Dose
OTHER: Placebo
DRUG: ORKA-001 Maintenance Dose

Sponsor

Oruka Therapeutics, Inc.